They found that an extract of turmeric beneficially affected the gene variants associated with IBD, by a reduction of inappropriate epithelial cell transport (SLC22A4, 503F) or through an increase in gene promoter activity of the IL10 anti-inflammatory cytokine (IL10, −1082A). This evidence concerns the gene IL10 and irritable bowel syndrome.